Varian Medical (NYSE:VAR) has joined a $30 million Series B round of financing for embolic therapy tech developer ABK Biomedical. Palo Alto, Calif.-based Varian Medical Systems led the round alongside F-Prime Capital, Halifax, Nova Scotia-based ABK Biomedical said. “ABK has a unique approach to address a large unmet need for patients with non-resectable liver tumors. This […]
Radiosurgery/Radiation therapy
AngioDynamics wins expanded FDA clearance for OARtrac radiation dose monitor
AngioDynamics (NSDQ:ANGO) said late yesterday that it won expanded FDA 510(k) clearance for its OARtrac radiation dose monitoring system. With the new clearance, the Latham, N.Y.-based company’s OARtrac system is cleared for use with patient-specific, pre-calibrated Plastic Scintillating Detector sensors used during cancer treatments to monitor photon and electron radiation therapy as an adjunct to treatment […]
Elekta wins Health Canada approval for Elekta Unity MR radiation therapy system
Elekta (STO:EKTA B) said today that it won Health Canada approval for its Elekta Unity magnetic resonance radiation therapy system. The Elekta Unity system consists of a high-field 1.5 Tesla MRI scanner and a linear accelerator alongside integrated real-time dose planning software for target monitoring, the Stockholm-based company said. Elekta added that its Elekta Unity device […]
GT Medical lands $10m Series A for IsoRay’s GammaTile
GT Medical Technologies said today that it landed a $10 million Series A round for the GammaTile brachytherapy it co-developed with IsoRay (NYSE:ISR) to treat brain tumors. Richland, Wash.-based IsoRay and the Barrow Neurological Institute formed GT Medical to develop the technology to embed Cesium-131 brachytherapy seeds in collagen tiles to treat malignant meningioma, according to regulatory filings, […]
Accuray’s fiscal Q2 earnings top expectations despite sales miss
Accuray (NSDQ:ARAY) this week posted fiscal second-quarter earnings that beat the consensus on Wall Street but missed sales expectations. The Sunnyvale, Calif.-based company put up losses of -$4.6 million, or -5¢ per share, on sales of $102.3 million for the three months ended YYdate, paring its losses by -1.7% on sales growth of 2.0% compared with […]
Sensus Healthcare closes $15m offering
Sensus Healthcare (NSDQ:SRTS) today closed an offering that raised approximately $15 million for the development of its superficial radiation therapy devices. In the offering, the Boca Raton, Fla.-based floated 2.2 million shares at $6.80 apiece, for gross proceeds just shy of $15.0 million. The offering also includes a 30-day underwriter’s option to purchase an additional 330,882 shares […]
Dune Medical debuts waste-saving surgical probe
Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to […]
Jury convicts four in CMS-Deerfield insider trading case
A federal jury yesterday reportedly convicted a Centers for Medicare & Medicaid Services worker and three others of using inside information as the “secret sauce” in a $7 million insider trading scheme with a well-known healthcare hedge fund. Consultant David Blaszczak, founder of Precipio Health Strategies and the one-time colleague at CMS of Christopher Worrall, pleaded not […]
Brainlab releases VersaHD high-res planning algorithm
Brainlab said today it launched a new high-res planning algorithm within its Brainlab Elements software to improve radiation dose conformity for treating brain tumors, and added that the algorithm is a result of its strategic collaboration Elekta (STO:EKTA B). The Munich-based company’s Elements system operates with Elekta’s Agility multileaf collimator to compensate for the width of […]
Feds: CMS insider’s ‘secret sauce’ drove NY hedge fund’s healthcare bets
Federal prosecutors yesterday reportedly accused a political consultant of using his contact at the Centers for Medicare & Medicaid Services as the “secret sauce” in a $7 million insider trading scheme with a well-known healthcare hedge fund. Consultant David Blaszczak, founder of Precipio Health Strategies and the one-time colleague at CMS of Christopher Worrall, pleaded […]
ViewRay adds another $59m from Chinese backer Fosun
ViewRay (NSDQ:VRAY) said it added another $59.1 million it its coffers in an equity and warrants sale to Chinese investment firm Fosun International, following a $50 million offering last year. Fosun, which took out a 9.9% stake in ViewRay last October in a $50 million round, is slated to own 18.4% of the Cleveland-area linear accelerator […]